Lipid-Lowering Efficacy of the Capsaicin in Patients With Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

BACKGROUND: Patients with metabolic syndrome (MetS) have increased cardiovascular risk. Capsaicin (CAP) has been shown to reduce lipids, but efficacy for patients with MetS is unknown. METHODS: A systematic review was performed according to PRISMA guidelines, to compare the effects of CAP against a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Zhonghui, Qu, Hua, Lin, Gongyu, Shi, Dazhuo, Chen, Keji, Gao, Zhuye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923259/
https://www.ncbi.nlm.nih.gov/pubmed/35299764
http://dx.doi.org/10.3389/fnut.2022.812294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923259/
https://www.ncbi.nlm.nih.gov/pubmed/35299764
http://dx.doi.org/10.3389/fnut.2022.812294

Ejemplares similares